Drug Store News hosted an exclusive reception last week in Providence, R.I., to mark the release of the October 2016 issue of DSN, which featured the special cover feature, “CVS Doubles Down on Health.” In all, more than 100 guests attended, including about 25 CVS executives and select members of the vendor community.
McKesson is updating its outlook from the previous range of $13.43 to $13.93 per diluted share to a new range of $12.35 to $12.85 per diluted share for the fiscal year ending March 31, 2017.
The primary challenges for the CPG industry operating in the natural and specialty space have been a lack of store-level visibility and the significant expense of supplying brand representatives in stores.
By the end of the year, GNC plans to deconstruct its pricing strategy, streamline its supply chain and digitize its marketing outreach, all in hopes of recapturing a supplement consumer who's migrated to other channels.
In the latest episode of DSNTV, associate publisher and editor in chief Rob Eder spoke with Trygve Anderson, clinical executive at Elsevier, about delivering drug information faster to customers. “[We] get the data in, including all product data and patient safety data, and we deliver it in a timely fashion,” Anderson said. “We don’t feel that a customer of ours should have to wait for data. And that allows us to create what we now coin as a ‘true daily update’ in order to better serve those customers.”
At its annual ThoughtSpot 2016 conference held in Las Vegas in late July, AmerisourceBergen outdid itself with the number of new tools designed to augment store operations, streamline pharmacy workflow and help better connect independent operators to several of their many healthcare stakeholders, including patients, payers and legislators.